Navigation Links
RxSafetyMatters Receives 2013 Communicator Award for its Mobile Site
Date:7/19/2013

STAMFORD, Conn., July 19, 2013 /PRNewswire/ -- RxSafetyMatters.org, an online resource about preventing prescription drug abuse, recently received the 2013 Communicator Award (CA) for best mobile site in the category of Health and Wellness.  The CA is the leading international awards program recognizing big ideas in marketing and communications.  Founded nearly two decades ago, CA receives over 6,000 entries from companies and agencies of all sizes, making it one of the largest awards of its kind in the world. 

(Logo:  http://photos.prnewswire.com/prnh/20100921/NY67262 )

(Logo: http://photos.prnewswire.com/prnh/20130719/NY49019LOGO )

Pharmaceutical company Purdue Pharma L.P. developed RxSafetyMatters.org as an online resource to help healthcare professionals, law enforcement personnel, and families and communities learn more about the dangers of illegal trafficking and abuse of prescription medications. The site provides information on programs and resources designed to help deter medication misuse and abuse. The RxSafetyMatters mobile site was introduced in 2012 and enables mobile users to optimize the website on a mobile device such as an iPhone, tablet, or a smartphone with a browser. 

"We thought it was important to design this resource to be mobile friendly given the growing number of people who are using handheld devices to search for information online," said Jim Heins, Senior Director, Public Affairs at Purdue Pharma.  "The mobile site allows users to easily read, download and share the resources offered on the site."

According to a new report from Walker Sands, mobile websites are not commonplace yet, but are steadily gaining popularity – this is because website traffic is increasingly coming through mobile devices. The percentage of website traffic coming from mobile devices jumped from 17.5% in Q3 2012 to 23.1% in Q4 2012.

To learn more about CA, visit http://www.communicatorawards.com

About Purdue Pharma L.P.
Purdue Pharma L.P. is a privately held pharmaceutical company, founded by physicians, that is engaged in the research, development, production, and distribution of prescription and over-the-counter medicines and healthcare products. The company is known for its pioneering research on pain, a principal cause of human suffering. Purdue Pharma L.P. has developed www.RxSafetyMatters.org to provide information and resources to help deter medication misuse and abuse.

About RxSafetyMatters
RxSafetyMatters connects healthcare professionals, families, communities, and law enforcement officials with programs focused on fighting prescription medication abuse and theft. Learn more about RxSafetyMatters at www.rxsafetymatters.org.


'/>"/>
SOURCE Purdue Pharma L.P.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Perrigo Receives FDA Tentative Approval For Generic Equivalent To Prandin(R)
2. Elekta Receives CE Marking for Clarity 4D Monitoring
3. SynGen Inc. Receives FDA 510K Clearance to Market SynGenX-1000 Cord Blood Processing Platform
4. Bison Stainless Tube Receives ISO 9001:2008 Certification
5. UCBs Kremers Urban Pharmaceuticals Inc. receives FDA approval for extended release methylphenidate hydrochloride
6. Society for Clinical Research Sites Receives Unprecedented Response from Industry Stakeholders to Support Sites by Joining Corporate Partnership Program
7. Prime Therapeutics receives prestigious Silver Anvil Award from Public Relations Society of America
8. HeartWare Receives Conditional Approval From FDA to Enroll Supplemental Patient Cohort in Destination Therapy Trial
9. Micell Technologies Receives CE Mark Approval for MiStent SES
10. Prime Therapeutics receives highest rating in 2013 customer satisfaction survey
11. KemPharm, Inc. Receives Patent from the USPTO for Novel Pain Drug Candidate, KP201
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 23, 2017  The particle counters market is ... from USD 275.9 million in 2016, at a ... report: http://www.reportlinker.com/p04718602-summary/view-report.html The growing ... R&D, and growth in manufacturing industries in emerging ... for particle counters. On the other hand, technical ...
(Date:2/23/2017)... , Feb 23, 2017 Research and ... Drugs Price Analysis and Strategies - 2016" report to their ... The ... 2016, provides drug pricing data and benchmarks in the global Autism ... What are the key drugs marketed for ...
(Date:2/23/2017)... REDWOOD CITY, Calif., Feb. 23, 2017 Nevro Corp. ... innovative evidence-based solutions for the treatment of chronic pain, today ... ended December 31, 2016. 2016 Accomplishment & ... the full year 2016, an increase of 228% as reported, ... million for 2016, an increase of 612% over the prior ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... February 24, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... present generation. Yisrayl makes an astounding statement when he says that the entire ... the Bible details the current times so plainly that anyone should be able to ...
(Date:2/24/2017)... ... February 24, 2017 , ... Rosica Communications, a ... thought leadership , media relations, social media, content marketing and SEO, is now ... through Act-On, an intuitive marketing automation platform. , Rosica will now offer the ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... Department of Justice jointly issued a letter to withdraw previous guidance ... with their gender identity. The guidance issued in May 2016 by the Obama ...
(Date:2/23/2017)... ... February 23, 2017 , ... The American Cleft Palate-Craniofacial Association (ACPA) ... Meeting. KLS is a longtime supporter of the event. , "We are pleased ... Sponsor," said Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has a long track ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... content provider for the National Institute for Health and Care Excellence ... organizations in the National Health Service (NHS) to search, order and purchase medical ...
Breaking Medicine News(10 mins):